title: [Oral 5-FU and digestive cancers].
authors.affiliation: Hépato-Gastroentérologie, Groupe Hospitalier Pitié Salpêtrière, Paris, France. jtaieb@club-internet.fr
authors.forename: Julien
authors.initials: J
authors.lastname: Taïeb
authors.forename: Jérome
authors.initials: J
authors.lastname: Desramé
authors.forename: Pascal
authors.initials: P
authors.lastname: Artru
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005472:Fluorouracil / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D005641:Tegafur / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*
chemical_list: D000964:Antimetabolites, Antineoplastic; D005641:Tegafur; D005472:Fluorouracil